HOUSTON, Oct. 29, 2020 /PRNewswire/ -- Soliton, Inc.,
(Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device
company with a novel and proprietary platform technology, announced
today that it will report its third quarter 2020 financial results
and provide a business update on Thursday,
November 12th, 2020 before the open of the U.S.
financial markets.
Management will host a conference call and live webcast to
discuss Soliton's financial results at 8:30
a.m. ET that same day. A question and answer session will
follow management remarks.
The dial-in numbers for the conference call are (833) 423- 0479
for domestic callers and (918) 922-2373 for international
callers. The conference ID is 3493411.
A replay of the call will be available following its completion
through November 19th,
2020. To access the replay, dial (855) 859-2056 for domestic
callers and (404) 537-3406 for international callers and use the
replay conference ID 3493411.
A live audio webcast of the call and an updated investor
presentation will be available on the Investor Relations page of
the Soliton, Inc. website, https://ir.soliton.com/. A replay
of the webcast will be archived on Soliton's website for 30 days
following the completion of the call.
Join our more than 200K
subscribers here to follow the
Company: https://soly-investors.com
About Soliton, Inc.
Soliton, Inc. is a medical device company with a novel and
proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer
Center. The Company's first FDA cleared commercial product will use
rapid pulses of acoustic shockwaves as an accessory to lasers for
the removal of unwanted tattoos. The Company is based in
Houston, Texas, and is actively
engaged in bringing the Rapid Acoustic Pulse ("RAP") device to the
market. The Company believes this "Soliton" method has the
potential to lower tattoo removal costs for patients, while
increasing profitability to practitioners, compared to current
laser removal methods. Soliton has filed a 510(k) application with
the FDA for clearance of its RAP device to improve the appearance
of cellulite and is investigating potential additional capabilities
of the RAP technology. The device is currently cleared in
the United States only for use in
tattoo removal and is not yet cleared for use to address
cellulite.
For more information about the Company, please visit:
http://www.soliton.com
Forward-Looking Statements
This press release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, Section
21E of the Securities Exchange Act of 1934 and the Private
Securities Litigation Reform Act of 1995, which statements involve
risks and uncertainties. These statements relate to future events,
future expectations, plans and prospects. Although Soliton believes
that the expectations reflected in such forward-looking statements
are reasonable as of the date made, actual results or outcomes may
prove to be materially different from the expectations expressed or
implied by such forward-looking statements. Soliton has attempted
to identify forward-looking statements by terminology including
''believes,'' ''estimates,'' ''anticipates,'' ''expects,''
''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,''
''could,'' ''might,'' ''will,'' "would," ''should,''
''approximately'' or other words that convey uncertainty of future
events or outcomes to identify these forward-looking statements.
These statements are only predictions and involve known and unknown
risks, uncertainties, and other factors, including those discussed
in our filings with the Securities and Exchange Commission ("SEC"),
including under the heading " Risk Factors" in the Form 10-K for
year ended December 31, 2019 filed
with the SEC and as updated in our Form 10-Q filings and in our
other filings with the SEC. Any forward-looking statements
contained in this release speak only as of its date. Soliton
undertakes no obligation to update any forward-looking statements
contained in this release to reflect events or circumstances
occurring after its date or to reflect the occurrence of
unanticipated events.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/soliton-announces-third-quarter-2020-financial-results-and-business-update-on-thursday-november-12th-2020-301162673.html
SOURCE Soliton, Inc.